Viewing Study NCT05669820


Ignite Creation Date: 2025-12-25 @ 4:08 AM
Ignite Modification Date: 2026-01-29 @ 9:33 AM
Study NCT ID: NCT05669820
Status: RECRUITING
Last Update Posted: 2024-02-05
First Post: 2022-12-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Antisecretory Factor Glioblastoma Phase 2
Sponsor: Peter Siesjö
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module